$LEXX Income Statement | Understand Stock

$LEXX

$3.77 +$0.47 (14.24%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Aug 31, 2025	FY2024 12 months to Aug 31, 2024	FY2023 12 months to Aug 31, 2023	FY2022 12 months to Aug 31, 2022	FY2021 12 months to Aug 31, 2021
Revenues
Cost of goods sold
Gross profit
Operating expenses
Research and development
General and administrative
Total operating expenses
Loss from operations
Gain on disposal of assets
Discontinued operations
Net loss and comprehensive loss for the year
Common shareholders
Interest income

Interest income
Unrealized loss on marketable securities
Total other income (loss)
Other income (loss)
Interest income
Unrealized loss on marketable securities
Total other income (loss)
Net loss
Less: Net loss attributable to non-controlling interest
Basic and diluted earnings (loss) per share from discontinued operations
Basic and diluted loss per share

Net loss attributable to Lexaria shareholders
Foreign currency translation adjustment
Other comprehensive income (loss)
Foreign currency translation adjustment
Total comprehensive loss
Basic and diluted loss per share
Weighted average number of common shares outstanding
- Basic and diluted
- Basic and diluted

Comments